Literature DB >> 9647533

Development of human primordial follicles to antral stages in SCID/hpg mice stimulated with follicle stimulating hormone.

K Oktay1, H Newton, J Mullan, R G Gosden.   

Abstract

In contrast to the many detailed studies of Graafian follicles, the biology of small follicles in the human ovary is poorly understood and the trigger for follicular growth initiation remains unknown. No practical model exists to study preantral follicle growth in the human because of their slow growth rate and lack of an effective culture system. We therefore tested ovarian xenografts as a new strategy to study the early stages of ovarian follicular growth in vivo. Mice homozygous for severe combined immunodeficiency (SCID) and hypogonadism (hpg) received human ovarian xenografts under their kidney capsules. Follicle growth was assessed by morphology and proliferating cell nuclear antigen (PCNA) immunostaining. The grafts were recovered after 11 (short-term) and 17 weeks (long-term), and serially sectioned. During the last 6 weeks of long-term grafting, mice were randomized to receive either placebo or 1 IU of purified follicle stimulating hormone (FSH) s.c. on alternating days. After 11 weeks of grafting, the most advanced follicles had a maximum of two granulosa cell layers. In the absence of FSH administration, follicles did not progress beyond the two-layer stage even after 17 weeks of grafting, and the oestradiol levels remained undetectable. In the FSH-treated long-term grafts, follicles had grown to antral stages and resulted in oestradiol levels as high as 2070 pmol/l. Growth initiation indices did not differ between control and FSH-treated grafts. This study demonstrates that follicles can survive and grow in human ovarian tissue grafted under the renal capsules of immunodeficient mice for at least 17 weeks, and indicate that xenograft models are potentially useful for studying human follicle development. Using this physiological model, we showed that FSH is required for follicle growth beyond the two-layer stage, although growth initiation is independent of gonadotrophin stimulation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9647533     DOI: 10.1093/humrep/13.5.1133

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  42 in total

Review 1.  Recent advances in oocyte and ovarian tissue cryopreservation and transplantation.

Authors:  Kenny A Rodriguez-Wallberg; Kutluk Oktay
Journal:  Best Pract Res Clin Obstet Gynaecol       Date:  2012-02-01       Impact factor: 5.237

Review 2.  Fertility preservation through gonadal cryopreservation.

Authors:  Lalitha Devi; Sandeep Goel
Journal:  Reprod Med Biol       Date:  2016-03-11

Review 3.  Recent advances in the field of ovarian tissue cryopreservation and opportunities for research.

Authors:  Camille Ladanyi; Amir Mor; Mindy S Christianson; Namisha Dhillon; James H Segars
Journal:  J Assist Reprod Genet       Date:  2017-04-01       Impact factor: 3.412

4.  In vitro culture of sheep lamb ovarian cortical tissue in a sequential culture medium.

Authors:  Xiayu Peng; Mei Yang; Liqin Wang; Chen Tong; Zhiqin Guo
Journal:  J Assist Reprod Genet       Date:  2010-05       Impact factor: 3.412

Review 5.  Applicability of adult techniques for ovarian preservation to childhood cancer patients.

Authors:  Laura Detti; Daniel C Martin; Lucy J Williams
Journal:  J Assist Reprod Genet       Date:  2012-07-21       Impact factor: 3.412

6.  Activin Decoy Receptor ActRIIB:Fc Lowers FSH and Therapeutically Restores Oocyte Yield, Prevents Oocyte Chromosome Misalignments and Spindle Aberrations, and Increases Fertility in Midlife Female SAMP8 Mice.

Authors:  Lori R Bernstein; Amelia C L Mackenzie; Se-Jin Lee; Charles L Chaffin; István Merchenthaler
Journal:  Endocrinology       Date:  2015-12-29       Impact factor: 4.736

7.  Blastocyst development after cryopreservation and subcutaneous transplantation of mouse ovarian tissue.

Authors:  Robert Kuo-Kuang Lee; Hsin-Yi Ho; San-Li Yu; Chung-Hao Lu
Journal:  J Assist Reprod Genet       Date:  2005-02       Impact factor: 3.412

8.  A factor analysis approach to examining relationships among ovarian steroid concentrations, gonadotrophin concentrations and menstrual cycle length characteristics in healthy, cycling women.

Authors:  E S Barrett; I Thune; S F Lipson; A-S Furberg; P T Ellison
Journal:  Hum Reprod       Date:  2012-12-18       Impact factor: 6.918

Review 9.  Preservation of fertility in women undergoing chemotherapy: current approach and future prospects.

Authors:  R Abir; B Fisch; A Raz; S Nitke; Z Ben-Rafael
Journal:  J Assist Reprod Genet       Date:  1998-09       Impact factor: 3.412

Review 10.  Orthotopic and heterotopic ovarian tissue transplantation.

Authors:  I Demeestere; P Simon; S Emiliani; A Delbaere; Y Englert
Journal:  Hum Reprod Update       Date:  2009-05-27       Impact factor: 15.610

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.